2Greenlee RT,Murray T,Bolden S,et al.Cancer statistics[J].CA Cancer J Clin,2000,50(1):7-33.
3Holmberg L,Bill-Axelson A,Helgesen F,et al.A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer[J].N Engl J Med,2002,347(11):781-789.
4Peschel RE,Colberg JW.Surgery,brachytherapy,and external-beam radiotherapy for early prostate cancer[J].Lancet Oncol,2003,4(4):233-241.
5Partin AW,Yoo J,Carter HB,et al.The use of prostate specific antigen,clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer[J].J Urol,1993,150(1):110-114.
6Civantos F,Marcial MA,Banks ER,et al.Pathology of androgen deprivation therapy in prostate carcinoma:acomparative study of 173 patients[J].Cancer,1995,75(7):1634-1641.
7Chacko KN,Donovan JL,Abrams P,et al.Transurethral prostatic resection or laser therapy for men with acute urinary retention:the clasprandomized trial[J].J Urol,2001,166(1):166-170.
8Moul JW.Prostate specific antigen only progression of prostate cancer[J].J Urol,2000,163(6):1632-1642.
3Stefanou D, Batistatou A, Kamina S, et al. Expression of vascular endothelial growth factor (VEGF) and association with mierovessel density in benign prostatic hyperplasia and prostate cancer[J].In Vivo, 2004, 18(2) : 155-160.
6Drudi FM, Giovagnorio F, Carbone A, et al. Transreetal eolour Doppler contrast sonography in the diagnosis of local recurrence after radieal prostateetomg-eomparison with MRI[J]. Ultrasehall Med, 2006,27(2) : 146-151.
7Prando A, Kurhanewiz J, Borges AP, et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy fingings: early experience[J]. Radiology, 2005, 236(3) : 903-910.
